Clinical Trial Update: A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery

View source ↗

Summary

A clinical trial comparing 0.5% loteprednol etabonate with 1% prednisolone acetate after cataract surgery to treat postoperative intraocular inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Inflammation

Drugs mentioned

• Lotemax (Loteprednol etabonate)
• PRED FORTE (Prednisolone acetate)

Snippet

Sponsor: Associated Eye Care, Minnesota | Conditions: Intraocular Inflammation | Status: COMPLETED